Trial · NCT03298451
Adverse events1,308
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 1,308
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Alanine aminotransferase increased | Investigations | Durva 1500 mg | 42 | 388 | 49 |
| other | Alanine aminotransferase increased | Investigations | Treme 300 mg x1 Dose + Durva 1500 mg | 35 | 388 | 45 |
| other | Alanine aminotransferase increased | Investigations | Treme 75 mg x4 Doses + Durva 1500 mg | 9 | 152 | 9 |
| other | Alanine aminotransferase increased | Investigations | Sora 400 mg | 20 | 374 | 26 |
| other | Amylase increased | Investigations | Durva 1500 mg | 9 | 388 | 11 |
| other | Amylase increased | Investigations | Treme 300 mg x1 Dose + Durva 1500 mg | 28 | 388 | 38 |
| other | Amylase increased | Investigations | Treme 75 mg x4 Doses + Durva 1500 mg | 6 | 152 | 6 |
| other | Amylase increased | Investigations | Sora 400 mg | 10 | 374 | 17 |
| other | Aspartate aminotransferase increased | Investigations | Durva 1500 mg | 54 | 388 | 63 |
| other | Aspartate aminotransferase increased | Investigations | Treme 300 mg x1 Dose + Durva 1500 mg | 46 | 388 | 53 |
| other | Aspartate aminotransferase increased | Investigations | Treme 75 mg x4 Doses + Durva 1500 mg | 16 | 152 | 17 |
| other | Aspartate aminotransferase increased | Investigations | Sora 400 mg | 24 | 374 | 33 |
| other | Blood bilirubin increased | Investigations | Durva 1500 mg | 23 | 388 | 30 |
| other | Blood bilirubin increased | Investigations | Treme 300 mg x1 Dose + Durva 1500 mg | 19 | 388 | 23 |
| other | Blood bilirubin increased | Investigations | Treme 75 mg x4 Doses + Durva 1500 mg | 4 | 152 | 5 |
| other | Blood bilirubin increased | Investigations | Sora 400 mg | 29 | 374 | 32 |
| other | Gamma-glutamyltransferase increased | Investigations | Durva 1500 mg | 12 | 388 | 12 |
| other | Gamma-glutamyltransferase increased | Investigations | Treme 300 mg x1 Dose + Durva 1500 mg | 18 | 388 | 18 |
| other | Gamma-glutamyltransferase increased | Investigations | Treme 75 mg x4 Doses + Durva 1500 mg | 7 | 152 | 7 |
| other | Gamma-glutamyltransferase increased | Investigations | Sora 400 mg | 19 | 374 | 24 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03298451/events